Adicet Bio ACET
NASDAQ ACET
$6.64 -0.50 (-7.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Adicet Bio (ACET) Construction in Progress (2020 - 2024)

Updated

Adicet Bio (ACET) posted Construction in Progress of $200,000 for Q4 2024, down 97.8% from $9 million a year earlier.

Analysis

Adicet Bio (ACET) Construction in Progress (2020 - 2024) Analysis & Trends

Since Q3 2020, Adicet Bio has reported Construction in Progress for 9 quarters.

  • Annual Construction in Progress shows a four-year compound annual growth rate of -36.0% (FY2020 to FY2024).
  • In prior years, Adicet Bio's Construction in Progress was $9 million in FY2023 (-3.2%), $9.3 million in FY2022 and $1.19 million in FY2020.
  • The Q4 2024 figure stands as the lowest quarterly Construction in Progress in data going back to Q3 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Adicet Bio 66.84 Mn -450.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 200,000.00
Dec 31, 2023 9.00 Mn
Sep 30, 2023 500,000.00
Jun 30, 2023 1.60 Mn
Mar 31, 2023 1.80 Mn
Dec 31, 2022 9.30 Mn
Mar 31, 2021 730,000.00
Dec 31, 2020 1.19 Mn
Sep 30, 2020 3.49 Mn
API Access

Adicet Bio Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=ACET&period=max&api_key=YOUR_API_KEY